MedWatch

Audientes facing headwinds, lowers sales outlook

The Danish hearing firm has adjusted its revenue expectations by millions of Danish kroner after a new product launch has been postponed until next year.

Steen Thygesen, CEO of Audientes | Photo: Audientes / PR

Audientes, which has one self-fitting hearing aid on the market, has revised its expectations for 2022, the company announces in a press release.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Bank believes in cancer approval for Genmab

In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.

Further reading

Related articles

Latest news

See all jobs